Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

1.1K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.1K
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

545
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
545
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

3.4K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
3.4K
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

711
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
711
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

2.1K
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
2.1K
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

423
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
423

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

From the Emergency Department, Directly to Ablation of Atrial Fibrillation: Rationale and Design of the EMERGE Cryo Study.

CJC open·2026
Same author

Ventricular dispersion and repolarization in Marfan syndrome: A clinical analysis.

Heart rhythm O2·2025
Same author

Response to: implantable cardiac devices in cardiac sarcoidosis-it's about preventing the unforeseeable.

European heart journal. Case reports·2023
Same author

Intermittent complete atrioventricular block in a 20-year-old woman with cardiac sarcoidosis: a case report.

European heart journal. Case reports·2022
Same author

Genetic and Clinical Predictors of Left Atrial Thrombus: A Single Center Case-Control Study.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2021
Same author

Supervised Obesity Reduction Trial for AF ablation patients: results from the SORT-AF trial.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2021

Video Experimental Relacionado

Updated: Mar 2, 2026

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

3.2K

Farmacoterapia de emergencia en arritmología

Boris A Hoffmann1

  • 1Klinik für Kardiologie - Rhythmologie, Asklepios Klinikum Harburg, Eißendorfer Pferdeweg 52, 21075, Hamburg, Deutschland. bo.hoffmann@asklepios.com.

Herzschrittmachertherapie & Elektrophysiologie
|March 1, 2026
PubMed
Resumen
Este resumen es generado por máquina.

La farmacoterapia rápida es crucial para las arritmias cardíacas agudas, incluidas las taquiarritmias ventriculares. Los fármacos antiarrítmicos establecidos y específicos son vitales para prevenir la inestabilidad hemodinámica y la mortalidad en la electrofisiología cardíaca de emergencia.

Palabras clave:
Fármacos antiarrítmicosFibrilación auricularBradicardiaTaquicardia supraventricularTaquicardia ventricular

Más Videos Relacionados

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
08:28

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus

Published on: April 5, 2011

18.2K
Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.9K

Videos de Experimentos Relacionados

Last Updated: Mar 2, 2026

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

3.2K
Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
08:28

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus

Published on: April 5, 2011

18.2K
Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.9K

Área de la Ciencia:

  • Electrofisiología Cardíaca Clínica
  • Medicina de Emergencia
  • Farmacología

Sus antecedentes:

  • Las arritmias cardíacas agudas son emergencias comunes y de importancia pronóstica.
  • Las arritmias van desde bradicardia y taquicardia supraventricular hasta taquiarritmias ventriculares potencialmente mortales y tormenta eléctrica.
  • La farmacoterapia rápida, estructurada y basada en guías es esencial para prevenir la inestabilidad hemodinámica y la mortalidad.

Objetivo del estudio:

  • Revisar la farmacoterapia esencial para las arritmias cardíacas agudas.
  • Destacar la importancia de los fármacos antiarrítmicos establecidos en entornos de emergencia.
  • Analizar el papel de agentes específicos en arritmias ventriculares complejas.

Principales métodos:

  • Revisión de las prácticas clínicas actuales y la literatura sobre el manejo de arritmias agudas.
  • Análisis de los criterios de selección de fármacos basados en el tipo de arritmia, el estado hemodinámico y los factores del paciente.
  • Discusión de agentes antiarrítmicos establecidos y menos comunes.

Principales resultados:

  • La selección de la medicación de emergencia depende de la arritmia, la hemodinámica y los factores del paciente.
  • Los fármacos antiarrítmicos clásicos, los agentes del nodo AV, los betabloqueantes, los bloqueadores de los canales de calcio, la adenosina, los glucósidos y las catecolaminas son clave.
  • Los fármacos establecidos siguen siendo importantes debido a la falta de nuevas aprobaciones; la procainamida y la mexiletina se consideran para arritmias ventriculares complejas.

Conclusiones:

  • El manejo eficaz de las arritmias cardíacas agudas depende de una farmacoterapia adecuada.
  • Los fármacos antiarrítmicos establecidos son la piedra angular del tratamiento de emergencia.
  • Los agentes especializados pueden ser cruciales para las arritmias ventriculares refractarias o complejas.